Eursurv. Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022

[tetano]

• Aida Peiró-Mestres[SUP]1,*[/SUP] , Irene Fuertes[SUP]2,*[/SUP] , Daniel Camprubí-Ferrer[SUP]1,*[/SUP] , María Ángeles Marcos[SUP]1,3,4[/SUP] , Anna Vilella[SUP]1,5[/SUP] , Mireia Navarro[SUP]3[/SUP] , Laura Rodriguez-Elena[SUP]3[/SUP] , Josep Riera[SUP]2[/SUP] , Alba Català[SUP]2[/SUP] , Miguel J Martínez[SUP]1,3,4,**[/SUP] , Jose L Blanco[SUP]4,6,**[/SUP] , on behalf of the Hospital Clinic de Barcelona Monkeypox Study Group[SUP]7[/SUP]

A monkeypox (MPX) outbreak has expanded worldwide since May 2022. We tested 147 clinical samples collected at different time points from 12 patients by real-time PCR. MPX DNA was detected in saliva from all cases, sometimes with high viral loads. Other samples were frequently positive: rectal swab (11/12 cases), nasopharyngeal swab (10/12 cases), semen (7/9 cases), urine (9/12 cases) and faeces (8/12 cases). These results improve knowledge on virus shedding and the possible role of bodily fluids in disease transmission.


https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.28.2200503